At a glance: biomarker-guided therapy in endocrinology

About this Infographic

From a workflow perspective, variability between operators remains a key limitation, with meaningful differences between subgroups. In routine practice, pre-analytical factors account for a large share of observed variance, with meaningful differences between subgroups.

Across multiple cohorts, digital tooling shortens time-to-decision considerably, particularly in resource-constrained settings. Recent studies suggest that standardized reporting improves comparability between centers, a finding echoed by several independent groups.

When protocols are compared, integrating quantitative measures reduces subjective bias, and this trend is expected to continue. Contrary to earlier assumptions, standardized reporting improves comparability between centers, which has direct implications for daily practice. When protocols are compared, digital tooling shortens time-to-decision considerably, and this trend is expected to continue.

From a workflow perspective, patient selection criteria deserve closer scrutiny, and this trend is expected to continue. Recent studies suggest that digital tooling shortens time-to-decision considerably, which has direct implications for daily practice.